Not Yet Recruiting A Study of AN4035 in Advanced Cancers With RAS Mutations and High CEACAM5 Expression NCT07686445 Conditions CEACAM5, RAS Mutation, Solid Tumor (Phase I) Locations Linear — Perth, Australia Scientia Clinical Research — Sydney, Australia View Trial Details
